BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

445 related articles for article (PubMed ID: 24335546)

  • 1. Quantitative cerebral perfusion imaging in children and young adults with Moyamoya disease: comparison of arterial spin-labeling-MRI and H(2)[(15)O]-PET.
    Goetti R; Warnock G; Kuhn FP; Guggenberger R; O'Gorman R; Buck A; Khan N; Scheer I
    AJNR Am J Neuroradiol; 2014 May; 35(5):1022-8. PubMed ID: 24335546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial spin labelling MRI for assessment of cerebral perfusion in children with moyamoya disease: comparison with dynamic susceptibility contrast MRI.
    Goetti R; O'Gorman R; Khan N; Kellenberger CJ; Scheer I
    Neuroradiology; 2013 May; 55(5):639-47. PubMed ID: 23404242
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of CBF Measured with Combined Velocity-Selective Arterial Spin-Labeling and Pulsed Arterial Spin-Labeling to Blood Flow Patterns Assessed by Conventional Angiography in Pediatric Moyamoya.
    Bolar DS; Gagoski B; Orbach DB; Smith E; Adalsteinsson E; Rosen BR; Grant PE; Robertson RL
    AJNR Am J Neuroradiol; 2019 Nov; 40(11):1842-1849. PubMed ID: 31694821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Arterial spin-labeling cerebral perfusion changes after revascularization surgery in pediatric moyamoya disease and syndrome.
    Quon JL; Kim LH; Lober RM; Maleki M; Steinberg GK; Yeom KW
    J Neurosurg Pediatr; 2019 Feb; 23(4):486-492. PubMed ID: 30738390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arterial spin-labeling MR imaging in Moyamoya disease compared with clinical assessments and other MR imaging findings.
    Noguchi T; Kawashima M; Nishihara M; Hirai T; Matsushima T; Irie H
    Eur J Radiol; 2013 Dec; 82(12):e840-7. PubMed ID: 24055185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Noninvasive Evaluation of CBF and Perfusion Delay of Moyamoya Disease Using Arterial Spin-Labeling MRI with Multiple Postlabeling Delays: Comparison with
    Hara S; Tanaka Y; Ueda Y; Hayashi S; Inaji M; Ishiwata K; Ishii K; Maehara T; Nariai T
    AJNR Am J Neuroradiol; 2017 Apr; 38(4):696-702. PubMed ID: 28209582
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arterial transit artifacts observed by arterial spin labeling in Moyamoya disease.
    Ukai R; Mikami T; Nagahama H; Wanibuchi M; Akiyama Y; Miyata K; Mikuni N
    J Stroke Cerebrovasc Dis; 2020 Sep; 29(9):105058. PubMed ID: 32807463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monitoring Cerebral Perfusion Changes after Revascularization in Patients with Moyamoya Disease by Using Arterial Spin-labeling MR Imaging.
    Lee S; Yun TJ; Yoo RE; Yoon BW; Kang KM; Choi SH; Kim JH; Kim JE; Sohn CH; Han MH
    Radiology; 2018 Aug; 288(2):565-572. PubMed ID: 29714677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying Hypoperfusion in Moyamoya Disease With Arterial Spin Labeling and an [
    Fan AP; Khalighi MM; Guo J; Ishii Y; Rosenberg J; Wardak M; Park JH; Shen B; Holley D; Gandhi H; Haywood T; Singh P; Steinberg GK; Chin FT; Zaharchuk G
    Stroke; 2019 Feb; 50(2):373-380. PubMed ID: 30636572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantification of cerebral blood flow in healthy volunteers and type 1 diabetic patients: comparison of MRI arterial spin labeling and [(15)O]H2O positron emission tomography (PET).
    van Golen LW; Kuijer JP; Huisman MC; IJzerman RG; Barkhof F; Diamant M; Lammertsma AA
    J Magn Reson Imaging; 2014 Dec; 40(6):1300-9. PubMed ID: 24214919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantitative H2[(15)O]-PET in Pediatric Moyamoya Disease: Evaluating Perfusion before and after Cerebral Revascularization.
    Kuhn FP; Warnock G; Schweingruber T; Sommerauer M; Buck A; Khan N
    J Stroke Cerebrovasc Dis; 2015 May; 24(5):965-71. PubMed ID: 25813061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arterial Spin Labeling MRI for Quantitative Assessment of Cerebral Perfusion Before and After Cerebral Revascularization in Children with Moyamoya Disease.
    Ha JY; Choi YH; Lee S; Cho YJ; Cheon JE; Kim IO; Kim WS
    Korean J Radiol; 2019 Jun; 20(6):985-996. PubMed ID: 31132824
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of global cerebral blood flow measured by phase-contrast mapping MRI with
    Vestergaard MB; Lindberg U; Aachmann-Andersen NJ; Lisbjerg K; Christensen SJ; Rasmussen P; Olsen NV; Law I; Larsson HB; Henriksen OM
    J Magn Reson Imaging; 2017 Mar; 45(3):692-699. PubMed ID: 27619317
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cerebral Blood Flow Improvement after Indirect Revascularization for Pediatric Moyamoya Disease: A Statistical Analysis of Arterial Spin-Labeling MRI.
    Blauwblomme T; Lemaitre H; Naggara O; Calmon R; Kossorotoff M; Bourgeois M; Mathon B; Puget S; Zerah M; Brunelle F; Sainte-Rose C; Boddaert N
    AJNR Am J Neuroradiol; 2016 Apr; 37(4):706-12. PubMed ID: 26585258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Noninvasive method for measurement of cerebral blood flow using O-15 water PET/MRI with ASL correlation.
    Okazawa H; Higashino Y; Tsujikawa T; Arishima H; Mori T; Kiyono Y; Kimura H; Kikuta KI
    Eur J Radiol; 2018 Aug; 105():102-109. PubMed ID: 30017265
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cerebral blood flow acquired by simultaneous [15O]water positron emission tomography and arterial spin labeling magnetic resonance imaging.
    Zhang K; Herzog H; Mauler J; Filss C; Okell TW; Kops ER; Tellmann L; Fischer T; Brocke B; Sturm W; Coenen HH; Shah NJ
    J Cereb Blood Flow Metab; 2014 Aug; 34(8):1373-80. PubMed ID: 24849665
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Delay Arterial Spin Labeling Provides More Accurate Cerebral Blood Flow Measurements in Moyamoya Patients: A Simultaneous Positron Emission Tomography/MRI Study.
    Fan AP; Guo J; Khalighi MM; Gulaka PK; Shen B; Park JH; Gandhi H; Holley D; Rutledge O; Singh P; Haywood T; Steinberg GK; Chin FT; Zaharchuk G
    Stroke; 2017 Sep; 48(9):2441-2449. PubMed ID: 28765286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arterial spin-labeling MR imaging in moyamoya disease compared with SPECT imaging.
    Noguchi T; Kawashima M; Irie H; Ootsuka T; Nishihara M; Matsushima T; Kudo S
    Eur J Radiol; 2011 Dec; 80(3):e557-62. PubMed ID: 21315533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simultaneous phase-contrast MRI and PET for noninvasive quantification of cerebral blood flow and reactivity in healthy subjects and patients with cerebrovascular disease.
    Ishii Y; Thamm T; Guo J; Khalighi MM; Wardak M; Holley D; Gandhi H; Park JH; Shen B; Steinberg GK; Chin FT; Zaharchuk G; Fan AP
    J Magn Reson Imaging; 2020 Jan; 51(1):183-194. PubMed ID: 31044459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reliability of two-dimensional and three-dimensional pseudo-continuous arterial spin labeling perfusion MRI in elderly populations: comparison with 15O-water positron emission tomography.
    Kilroy E; Apostolova L; Liu C; Yan L; Ringman J; Wang DJ
    J Magn Reson Imaging; 2014 Apr; 39(4):931-9. PubMed ID: 24038544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.